California is making history. Governor Gavin Newsom announced that starting January 1, 2026, the state will become the first in the U.S. to sell its own insulin. The price? Just $11 per pen.
This is a huge deal. Currently, a single pen of insulin can cost anywhere from $89 to $411. For many diabetics, these high prices force tough choices between medication and other essentials. California is changing that.
The insulin, branded under CalRx, is interchangeable with Lantus®, one of the most widely used insulins. Pharmacies in California will be able to get a five-pack for $45, meaning the savings will reach patients directly.
How did this happen? California partnered with nonprofit Civica Rx and Biocon Biologics back in 2023. With $50 million in funding, the initiative aims to make affordable insulin widely available. Civica Rx will also distribute its low-cost insulin nationally, helping even more people in need.
Governor Newsom said the state took matters into its own hands because the pharmaceutical industry “didn’t do the right thing.” He emphasized that California is committed to making healthcare affordable for millions of residents.
This move could help 3.5 million adults with diabetes in California. Beyond the state, it may even influence national drug prices, pressuring pharmaceutical companies to rethink how insulin is priced.
For many families, this announcement is more than just numbers—it’s a lifeline. Affordable insulin can save lives, reduce stress, and make sure no one has to choose between their health and other essentials.
Tags:
Trending